Eurofins CDMO
keyboard_backspaceBack to Home
Contact
2 bis avenue de Gascogne
31470 Fontenilles
France
Head of Sales
About us
Eurofins CDMO is a group of companies specialized in contract development and manufacturing (CDMO). The European network includes four operational sites in France (Saint‑Gély‑du‑Fesc, Artigues, Idron and Lentilly), as well as a site in Ghent, Belgium.
Eurofins CDMO sites operate fully certified, approved and inspected GMP facilities, with dedicated analytical development and formulation capabilities supporting the production of clinical batches, small commercial batches and orphan drugs.
Business offer
Eurofins CDMO in Europe provides integrated solutions for the development and bioproduction of antibodies, proteins, enzymes, vaccines and various types of bacteria. These services include the manufacturing of cell banks from research cell banks to Master Cell Banks, Working Cell Banks and end‑of‑production banks.
Our teams also develop innovative formulations for liquid and solid forms of proteins, oligonucleotides, peptides or microorganisms, tailored to a wide range of administration routes.
We ensure the manufacturing of sterile finished products (vials, prefilled syringes, lyophilized products) and non‑sterile products, covering all pharmaceutical dosage forms: solid (tablets, capsules), semi‑solid (gels, creams) and liquid (solutions, suspensions, including nanosuspensions).
We also offer comprehensive programs for the development and validation of analytical methods, as well as the assessment of the stability of active substances and finished products: accelerated stability, ICH, in‑use stability and ASAP studies (Accelerated Stability Assessment Program).
Finally, one of our sites specializes in secondary packaging, labeling, GMP storage, Qualified Person (QP) services, logistics and distribution, providing full support for clinical trials.
Activities
- Service
- Cardiology
- Genetic Diseases
- Oncology
- Nervous Central System
- Hematology
- Infectiology
- Immunology
- Ophthalmology
- Inflammation
- Other
- CMC
- Master Cell Bank
- Cell Line development
- Clone selection
- Characterization
- Analytical development
- Cell Culture
- Media composition
- Bioreactor conditions
- Gene modification / Transduction
- Retroviral & lentiviral vectors
- Cell expansion
- Stirred tank reactors
- Bioproduction
- Batches production type
- Mammalian
- Yeast
- Bacterial
- GLP compliance
- GMP compliance
- Pilot Batches
- Tests
- Optimization
- Scale-Up process
- Process optimization & validation
- Volume
- Preclinical / Tox
- Low volume (< 200 L)
- USP (Scale-Up)
- Cell expansion
- Inoculation
- Low volume containers to Bioreactors
- DSP (Recovery)
- Harvest
- Filtration
- Purification
- Fill & Finish
- Aseptic filling
- Lyophilization
- Batch release
- Storage matter
- Instruction
- Logistic
- Cell cryopreservation
- Controlled-rated freezer
- thaw
- Quality assurance, quality control & analytical process
- Stability Assessment
- Physical & chemical profile
- Shear/shaking
- Viscosity
- Photostability
- pH
- Freeze/thaw
- Heat/degradation
- Aggregation
- Cell line analytical development
- Host cell proteins
- Viral clearance
- Contaminants detection
- Biosafety & Bioanalysis
- Toxicology
- PK/PD features
- Impurities detection
- Bioproduction analytical test
- Monitoring
- Characterization
- Batch consistency
- Batch release test
- Chemical, physical, biological test
- Quality control test support
- Post-production test
- Real-time stability test
- Formulation
- Formulation
- Dose
- Stability
- Excipients
- Adjuvants
- Sterilization
- Lyophilization
- Storage stability
- Delivery
- Route of Administration
- Devices associated
- Clinical trials
- Phase I
- Phase II
- Phase III
- Vaccine: antigen format platforms
- Recombinant protein expression
- Bacterial
- Cell
- Synthetic Peptides or oligomers
- Virus-like particles (VLP) and nanoparticle-based carriers
- Killed/inactivated virus
- Live attenuated virus
- Viral vector encoding target antigen
- DNA plasmid vaccine
- mRNA vaccine
- Lipid delivery vehicle
- CMC
- GLP compliance
- for preclinical NCS (non-clinical safety) studies
- viral safety testing
- GMP compliance
- Master Banks (cell and viral as needed)
- manufacturing
- Characterization and testing
- storage
- shipment
- Cell Culture / Fermentation
- media formulation and supply
- Bioreactor conditions (cell in suspension, adherent cell player)
- Ability to work in BSL2 conditions
- Cell expansion
- Single use technology (SUS)
- Wave-mixed bioreactors
- Stirred tank reactors
- Gene modification / Transduction
- Molecular biology
- Expression systems
- Formulation
- Formulation
- Adjuvants
- Stabilization
- Excipients
- Vaccines Combination
- Lyophilization
- Shipment Monitoring
- Vaccine delivery/Administration routes
- Route of Administration
- Intramuscular route
- intradermal route
- Nasal route
- Mucosal routes
- Other devices: specify
- Delivery/ Encapsulation
- Polymeric Nanoparticles
- Lipid Nanoparticles
- Nano emulsions
- Adjuvanted delivery systems
- Clinical trials
- Phase I
- Phase II (human challenge trials)
- Phase III (large population pending pathogen prevalence)
- Bioproduction GMP
- Vaccine platform type
- Recombinant protein expression
- Synthetic Peptides or oligomers
- Virus-like particles (VLP) and nanoparticle-based carriers
- killed/inactivated virus
- Live attenuated virus
- Viral vector encoding target antigen
- DNA plasmid vaccine
- mRNA vaccine
- Lipid delivery vehicle
- Pilot Batches scale
- Process development & optimization
- Scale-Up & Validation
- Comparability characterization protocol
- Manufacturing Volume
- Small volume (< 100 L) adjusted to phase I/II needs: specify volume
- USP (Scale-Up)
- DSP (Recovery)
- Fill & finish
- Lyophilization
- Prefilled syringe
- Vaccine shipment and distribution
- Storage matter
- Labelling
- Packaging for shipping
- Instruction Label
- Cold chain logistics
- Quality control & analytical process monitoring
- Stability Assessment
- Batch release test
- Chemical, physical, biological testing
- Potency assay
- Impurities detection
- Quality control test support
